Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001577267 | SCV001804618 | likely benign | not provided | 2019-11-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001577267 | SCV002406030 | benign | not provided | 2025-01-21 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV002248740 | SCV002519083 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001577267 | SCV005436006 | likely benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | DCHS1: BS2 |
Foundation for Research in Genetics and Endocrinology, |
RCV000504966 | SCV000586695 | pathogenic | Van Maldergem syndrome 1 | 2016-03-05 | no assertion criteria provided | clinical testing | This variant has been reported in 1000 Genomes and ExAC databases. This variant is predicted to be probably damaging by PolyPhen-2 and damaging by LRT and Mutation Taster. |
Reproductive Health Research and Development, |
RCV000504966 | SCV001142417 | uncertain significance | Van Maldergem syndrome 1 | 2020-01-06 | no assertion criteria provided | curation | NM_003737.2:c.2382G>C in the DCHS1 gene has an allele frequency of 0.008 in South Asian subpopulation in the gnomAD database. It has not been reported previously as a pathogenic variant nor as a benign variant. We interpret it as variant of uncertain significance (VUS). ACMG/AMP criteria applied: Null. |